Top Markets
#1 Brevis Brevis +37.75%
#2 Talus Network Talus Network +30.27%
#3 Tung Tung Tung Sahur Tung Tung Tung Sahur +30.12%
#4 Keep Network Keep Network +29.03%
#5 MemeCore MemeCore +24.60%
#6 Infinity Ground Infinity Ground +22.76%
#7 Allora Allora +20.35%
#8 Starpower Starpower +20.08%
#9 Synapse Synapse +18.93%
#10 屎壳郎 (Dung Beetle) 屎壳郎 (Dung Beetle) +18.73%
Coin of the day
Brevis Brevis
설정
언어
한국어
통화
USD
테마
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
주식 순위 #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
주가
$0.20342561
시가총액
$1.34M
변동 (1일)
-1.44%
변동 (1년)
-65.74%
국가
FR
거래 IntegraGen SA (ALINT)

카테고리

Healthcare
IntegraGen SA (ALINT)의 발행 주식 수
December 2025 기준 발행 주식 수: 6.87M
IntegraGen SA의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 6.87M입니다. December 2023 말 기준 회사는 6.61M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
IntegraGen SA (ALINT)의 발행 주식 수 기록 (2008 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 6.87M 1.95%
2024 6.74M 1.87%
2023 6.61M -0.22%
2022 6.63M 0.14%
2021 6.62M -0.41%
2020 6.65M 2.44%
2019 6.49M 0.35%
2018 6.46M -0.27%
2017 6.48M 29.14%
2016 5.02M -0.17%
2015 5.03M 1.70%
2014 4.94M 20.14%
2013 4.12M 0.00%
2012 4.12M 9.12%
2011 3.77M 0.00%
2010 3.77M 26.93%
2009 2.97M 0.00%
2008 2.97M 0.00%
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.44B 64,584.67%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 254.10M 3,599.77%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 104.00M 1,414.27%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 2,666.41%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M 794.28%
NL